NCT02178670View on ClinicalTrials.gov

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Neoplasms,Ovarian
Interventions
BIOLOGICAL

CSC-DC

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02178670 - Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine | Biotech Hunter | Biotech Hunter